Crossmark Global Holdings’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.5M Buy
146,708
+694
+0.5% +$60.7K 0.17% 134
2026
Q1
$12.4M Sell
146,014
-7,554
-5% -$673K 0.18% 132
2025
Q4
$12.1M Sell
153,568
-37,096
-19% -$2.91M 0.17% 138
2025
Q3
$15.2M Buy
190,664
+3,517
+2% +$300K 0.23% 104
2025
Q2
$17M Buy
187,147
+2,170
+1% +$198K 0.27% 83
2025
Q1
$17.3M Buy
184,977
+11,146
+6% +$998K 0.31% 79
2024
Q4
$15.8M Buy
173,831
+7,105
+4% +$678K 0.29% 81
2024
Q3
$17.3M Buy
166,726
+96,680
+138% +$9.85M 0.31% 73
2024
Q2
$6.8M Sell
70,046
-5,099
-7% -$470K 0.13% 183
2024
Q1
$6.77M Sell
75,145
-5,815
-7% -$493K 0.13% 184
2023
Q4
$6.45M Buy
80,960
+13,315
+20% +$1M 0.13% 182
2023
Q3
$4.7M Sell
67,645
-643
-0.9% -$48.1K 0.11% 221
2023
Q2
$5.16M Sell
68,288
-3,334
-5% -$258K 0.11% 214
2023
Q1
$5.38M Sell
71,622
-975
-1% -$72.5K 0.13% 198
2022
Q4
$5.72M Buy
72,597
+3,522
+5% +$264K 0.14% 182
2022
Q3
$4.85M Sell
69,075
-742
-1% -$58.2K 0.13% 188
2022
Q2
$5.59M Buy
69,817
+640
+0.9% +$50K 0.15% 174
2022
Q1
$5.25M Buy
69,177
+2,590
+4% +$205K 0.12% 202
2021
Q4
$5.68M Sell
66,587
-160
-0.2% -$12.5K 0.12% 184
2021
Q3
$5.04M Buy
66,747
+1,028
+2% +$81.6K 0.12% 192
2021
Q2
$5.35M Buy
65,719
+527
+0.8% +$43.1K 0.13% 176
2021
Q1
$5.14M Buy
65,192
+667
+1% +$52.3K 0.13% 180
2020
Q4
$5.52M Sell
64,525
-3,482
-5% -$288K 0.14% 168
2020
Q3
$5.25M Sell
68,007
-1,338
-2% -$102K 0.15% 163
2020
Q2
$5.08M Buy
69,345
+4,427
+7% +$314K 0.15% 154
2020
Q1
$4.31M Buy
64,918
+714
+1% +$50.4K 0.15% 158
2019
Q4
$4.42M Sell
64,204
-252
-0.4% -$17.2K 0.12% 194
2019
Q3
$4.74M Sell
64,456
-7,428
-10% -$539K 0.14% 179
2019
Q2
$5.15M Sell
71,884
-423
-0.6% -$30K 0.14% 174
2019
Q1
$4.96M Sell
72,307
-2,376
-3% -$153K 0.14% 179
2018
Q4
$4.45M Sell
74,683
-12,913
-15% -$808K 0.14% 181
2018
Q3
$5.87M Sell
87,596
-6,620
-7% -$441K 0.15% 164
2018
Q2
$6.11M Sell
94,216
-4,292
-4% -$281K 0.16% 146
2018
Q1
$7.06M Sell
98,508
-27,343
-22% -$1.97M 0.18% 136
2017
Q4
$9.49M Buy
125,851
+5,524
+5% +$403K 0.23% 104
2017
Q3
$8.77M Buy
+120,327
New +$8.67M 0.23% 110
2016
Q3
$8.77M Buy
+120,327
New +$8.9M 0.23% 110

Other funds holding CL

Crossmark Global Holdings's CL Position: Q2 2026 in Review

Crossmark Global Holdings increased its Colgate-Palmolive (CL) stake by 0.48% in Q2 2026, buying an estimated $60.7K and bringing the position to 146,708 shares worth $13.5M. The position accounts for 0.17% of the portfolio, ranked #134.

Crossmark Global Holdings first reported a position in CL in Q3 2016 and has held it in 37 quarters since. The position peaked at $17.3M in Q1 2025. 383 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Crossmark Global Holdings held 146,708 shares of Colgate-Palmolive worth $13.5M as of Q2 2026.
  • Crossmark Global Holdings bought 694 Colgate-Palmolive shares in Q2 2026, an estimated $60.7K.
  • Colgate-Palmolive made up 0.17% of Crossmark Global Holdings's portfolio in Q2 2026, its #134 holding.
  • Crossmark Global Holdings first reported a position in Colgate-Palmolive in Q3 2016 and has held it in 37 quarters since.
  • Crossmark Global Holdings's Colgate-Palmolive position peaked at $17.3M in Q1 2025.
  • 383 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.